Novarad
Novarad is a privately held medical imaging software company providing enterprise PACS, mammography, cardiology, radiation dose monitoring, mobile EMR, and FDA-cleared AR surgical navigation solutions to hospitals, imaging centers, and radiology groups worldwide.
- Company typePrivate
- Founded1988
- HeadquartersProvo, Utah, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Novarad does
Novarad is a privately held enterprise medical imaging software company founded in 1988 by Dr. Wendell Gibby, a practicing neurointerventional radiologist, and headquartered in Provo, Utah with a regional office in Makati City, Philippines. The company provides an integrated suite of imaging solutions spanning enterprise PACS, mammography, cardiology, radiation dose monitoring, augmented reality surgical navigation, mobile EMR, and AI-augmented triage, deployed across cloud, on-premises, edge, and hybrid models for hospitals from 26-bed critical access facilities up to 500+ bed health systems, as well as imaging centers, radiology groups, and surgical/orthopedic practices. Its flagship NovaPACS Enterprise Imaging platform is complemented by MammoIQ (breast imaging with BI-RADS/MQSA compliance), NovaCardio, NovaDose, NovaRIS, MobileRAD, CryptoChart (encrypted QR-code image sharing), SnapView (HIPAA-compliant mobile capture), and Ncompass (zero-footprint universal viewer). VisAR is the first fully immersive 3D AR surgical navigation system to receive FDA de novo clearance for spine surgery, built on Microsoft HoloLens, with an additional Indonesian Ministry of Health clearance and a court-affirmed '807 patent.
The technology foundation combines DICOM/HL7/FHIR interoperability with deep integration partnerships across Epic, Cerner, AthenaHealth, and 30+ other EHR/EMR platforms, plus alliances with Microsoft (HoloLens, Azure), Intel, Nuance, Twilio, Lenovo, and specialty AI partners including CureMetrix, ScreenPoint Medical, and Volpara. AI capabilities include AI-powered triage and workflow automation in MammoIQ and a free Azure-hosted NovaradAI COVID-19 Diagnostic Assistant that analyzes chest CTs through five consecutive AI models.
Revenue is generated primarily through enterprise software licensing (subscription, annual billing cadence) of NovaPACS and specialty modules, quote-based pricing scaled to facility size, professional services and 24/7 USA-based implementation support, hardware sales of the VisAR AR system, and usage-based fees from CryptoChart (less than $1 per study). Go-to-market combines direct enterprise field sales targeting C-suite, radiology, and IT decision-makers with channel partnerships (BlueStar Radiology, Criterions, Medtech) and EHR-vendor co-marketing, plus a website-led demo motion for mid-market facilities. The company markets through a blog, LinkedIn/X/Facebook/Instagram presence, industry conferences (SIR, AAOS), podcasts, and PR coverage, and reports a 99.99% uptime SLA for NovaPACS deployments and a 28% reduction in radiology reading time when RIS is integrated with PACS.
Novarad firmographics
Firmographics- Name
- Novarad
- Legal name
- Novarad Corporation
- Website
- https://novarad.net
- Company type
- Private
- Founded year
- 1988
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Novarad is a privately held medical imaging software company providing enterprise PACS, mammography, cardiology, radiation dose monitoring, mobile EMR, and FDA-cleared AR surgical navigation solutions to hospitals, imaging centers, and radiology groups worldwide.
- Ownership category
- akta.pro rank
Where Novarad is headquartered
LocationHeadquarters
- HQ city
- Provo, Utah
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Novarad business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Enterprise Imaging/PACS Software Licenses: Novarad generates revenue primarily through enterprise software licensing of its NovaPACS, enterprise imaging, and specialty imaging solutions (mammography, cardiology) to hospitals, imaging centers, and radiology groups. Solutions are deployed either as cloud-based, on-premises, or hybrid models. The company offers implementation services and technical support as part of the deployment.
- CryptoChart Per-Study Fees: CryptoChart medical image sharing product is priced at less than $1 per study, representing a usage-based or per-transaction revenue stream for sharing medical images via QR codes.
- Professional Services and Implementation: Implementation services, technical support, and training services associated with deploying enterprise imaging solutions. The company maintains 24/7 USA-based customer support.
- VisAR AR Surgical Navigation: Augmented reality surgical navigation system with FDA clearance for spine surgery, representing a specialized medical device revenue stream.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise hospital solutions - customizable based on hospital size |
| Unit Pricing | Pay-as-you-go | CryptoChart image sharing |
| Subscription | Annual | NovaDose dose monitoring |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels9 records
Novarad product offering
Product offeringCore offering
Novarad develops and sells enterprise medical imaging software for hospitals and clinics, including the NovaPACS enterprise imaging platform, the Nova RIS radiology information system, mammography and cardiology PACS products, dose monitoring and image-exchange tools, and an FDA-cleared augmented-reality surgical navigation system called VisAR. Its software runs on-premises, in a private cloud, or via Azure-hosted Nova Cloud, and integrates with major EHR/EMR systems.
Product overview
Novarad is an enterprise medical imaging software company offering a modular platform-plus-products architecture. The core platform is NovaPACS EI (Enterprise Imaging), a unified PACS/enterprise imaging system spanning radiology, mammography, breast care (MammoIQ), and cardiology (NovaCardio), with flexible deployment across cloud, on-premises, edge, and hybrid models. The portfolio extends into AR surgical navigation (VisAR — FDA-cleared immersive 3D AR system for spine and cranial surgery), mobile EMR (MobileRAD), radiation dose monitoring (NovaDose), image/sharing via encrypted QR codes (CryptoChart), radiology information management (Nova RIS), and a COVID-19 AI diagnostic tool. Supporting infrastructure includes Ncompass (universal viewer and enterprise imaging interface), and SnapView (HIPAA-compliant mobile capture). Products support HL7/FHIR interoperability and integrate with major EHR platforms (Epic, Cerner, Athenahealth, eClinicalWorks, NextGen) and specialty tools. The company has over 30 years of experience serving hospitals, imaging centers, and radiology groups.
Differentiator
Problem solved
Functional benefit
Brands
- NovaPACS: Enterprise imaging and Picture Archiving and Communication System for hospitals and imaging centers
- NovaRIS
- NovaCardio
- CryptoChart
- VisAR
- MobileRAD
- MammoIQ
- NovaDose
- Ncompass
- SnapView
Products and services
- NovaPACS Enterprise Imaging (EI)
Quantifiable outcome
- 28% reduction in radiology reading time when RIS is integrated with PACS
- +4 more outcomes
Companies that use Novarad
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
Novarad technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature10 records
Novarad partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- IkonopediacoreNovarad partnered with Ikonopedia to enhance clinical excellence with a complete breast care platform, NovaMG Pro. This partnership provides radiologists with next-generation breast imaging solutions combining Novarad's mammography PACS with Ikonopedia's breast imaging reporting and tracking system.
- EpiccoreIntegration partnership enabling Epic EHR customers to access Novarad enterprise imaging and PACS solutions with seamless interoperability. Deep integration allows image-enabled EMR workflows.
- CernercoreIntegration partnership with Cerner for enterprise imaging and PACS interoperability with Cerner Millennium EHR platform.
- AthenaHealthcoreIntegration partnership for healthcare imaging workflow integration with AthenaHealth's network-based healthcare services platform.
- eClinicalWorkscoreIntegration partnership for seamless data exchange between Novarad imaging solutions and eClinicalWorks EHR/PM platform.
- MedentcoreIntegration partnership with Medent for EHR and practice management interoperability.
- NextGencoreIntegration partnership for NextGen EHR platform connectivity and data exchange.
- Veradigm (formerly Allscripts)coreIntegration partnership for enterprise imaging connectivity with Veradigm's healthcare IT solutions.
- BlueStar RadiologyminorChannel partnership for radiology solutions distribution.
- CriterionsminorChannel partnership for healthcare IT solutions distribution.
- MedtechminorChannel partnership for medical technology distribution.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Novarad competitors and assessment
Company assessmentEmerging players
- Mach7 Technologies: Mach7 provides enterprise imaging and VNA solutions that compete with parts of the NovaPACS portfolio, particularly on image management and interoperability for multi-site hospitals.
- Brainlab: Brainlab is a direct peer in AR/spatial computing surgical navigation, including spine and cranial procedures where Novarad's VisAR is positioned. Comparable to VisAR on surgical navigation use cases and clinical evidence generation.
- Volpara Health: Volpara provides AI-driven breast density and mammography quality software that integrates into mammography workflows similar to Novarad's MammoIQ. The two are listed partners but compete on mammography AI and reporting.
Broad incumbents
- Fujifilm Healthcare (Synapse): Fujifilm's Synapse PACS and enterprise imaging portfolio competes with NovaPACS across enterprise hospitals. As a larger medical imaging incumbent, it bundles imaging with broader modality and IT offerings.
- GE HealthCare (Centricity PACS / TruePACS): GE HealthCare offers enterprise PACS, imaging analytics, and AI orchestration competing with NovaPACS. As one of the largest medical imaging incumbents, it competes on enterprise contracts, advanced visualization, and AI integration.
- Siemens Healthineers (syngo.plaza): Siemens syngo.plaza PACS and teamplay digital health platform compete with Novarad in large hospital and IDN deployments. Siemens combines imaging IT with modality hardware and AI-driven advanced visualization.
- Philips (IntelliSpace PACS): Philips IntelliSpace PACS and enterprise imaging solutions compete with Novarad at large hospital systems. Philips bundles imaging within a broader diagnostic and patient monitoring portfolio, often competing on integrated enterprise deals.
Direct peers
- Sectra: Sectra provides enterprise imaging PACS and specialty viewers for radiology, mammography, cardiology, and pathology. Like Novarad, it focuses on integrated enterprise imaging with strong customer outcomes in reading workflow.
- Agfa HealthCare (Agfa-Gevaert): Agfa's Enterprise Imaging platform directly competes with NovaPACS EI in PACS, RIS, and specialty imaging. Both target enterprise hospitals with modular, integrated imaging portfolios.
- Carestream Health: Carestream offers a competing enterprise imaging/PACS platform (Vue) plus specialty modules across radiology, mammography, and cardiology. It is one of the closest direct competitors to Novarad's NovaPACS Enterprise Imaging suite in the mid-market hospital segment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Customer concentration
Novarad social profiles
Digital presenceNovarad compliance and trust
Trust signalCompliance3 records
Novarad financial estimates
Financial estimateRevenue estimate
Valuation estimate
Novarad leadership team
Management profileNumber of profiles
Profiles10 records
Novarad funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Novarad M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Novarad
What does Novarad do?
Novarad develops and sells enterprise medical imaging software for hospitals and clinics, including the NovaPACS enterprise imaging platform, the Nova RIS radiology information system, mammography and cardiology PACS products, dose monitoring and image-exchange tools, and an FDA-cleared augmented-reality surgical navigation system called VisAR. Its software runs on-premises, in a private cloud, or via Azure-hosted Nova Cloud, and integrates with major EHR/EMR systems.
Is Novarad a public or private company?
Novarad is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Novarad founded?
Novarad was founded in 1988. It employs 101 to 250 people.
Where is Novarad based?
Novarad is headquartered in Provo, Utah, United States, in the North America region.
How does Novarad make money?
Four revenue lines are on record. Enterprise Imaging/PACS Software Licenses are the primary driver. The others are cryptoChart Per-Study Fees, professional Services and Implementation and visAR AR Surgical Navigation.
Who are Novarad's main competitors?
Emerging players on record are Mach7 Technologies, Brainlab and Volpara Health. Broad incumbents are Fujifilm Healthcare (Synapse), GE HealthCare (Centricity PACS / TruePACS), Siemens Healthineers (syngo.plaza) and Philips (IntelliSpace PACS). Direct peers are Sectra, Agfa HealthCare (Agfa-Gevaert) and Carestream Health.
Does Novarad have an API?
No public API is recorded for Novarad.